ESAIC Academy

Gender Differences in Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Treatment of Acute Moderate-to-Severe Pain
ESAIC Academy. DIDONATO K. 06/04/18; 220473; 08AP07-10
Karen DIDONATO
Karen DIDONATO
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies